Report #2854239

Received Aug 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 3 yrs
State: TX
Recovered: Unknown
Vaccinated: Aug 5, 2025
Onset: Aug 5, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	HR4RB	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Havrix adult dose administered to pediatric patient; Havrix adult dose administered to pediatric patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult product administered to child in a 3-year-old male patient who received HAV (Havrix adult) (batch number HR4RB, expiry date 18-DEC-2025) for prophylaxis. On 05-AUG-2025, the patient received Havrix adult. On 05-AUG-2025, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: Havrix adult dose administered to pediatric patient) and overdose (Verbatim: Havrix adult dose administered to pediatric patient). The outcome of the adult product administered to child and overdose were not applicable. Additional Information: GSK receipt date: 05-AUG-2025 The nurse called to report a pediatric patient of 3 years and 8 months was given an adult dose of the Havrix vaccine which led to adult product administration to child and overdose.